Navigation Links
International research team reports major findings in prevention and treatment of blood clots
Date:1/11/2011

A worldwide research consortium that includes the University of Oklahoma Health Sciences Center has proven that a new drug is more effective and easier to use than current medicines in the prevention of blood clots following hip replacement surgery.

The results reveal a better way to prevent the formation of blood clots in the deep veins of the legs a condition known as deep vein thrombosis (DVT). The blood clots become life-threatening pulmonary embolisms (PE) when they break free and travel to the lungs.

Gary Raskob, Ph.D., an internationally recognized DVT expert and dean of the OU College of Public Health, was co-author and a co-director of the study, which appears as the lead article in this week's issue of The New England Journal of Medicine. The study compared the drug Apixaban, given orally twice a day, to the current standard medicine, Enoxaparin, given twice daily by injection under the skin.

The randomized, double-blind trial involved more than 5,000 patients and showed Apixaban reduced the risk of blood clots, without increasing bleeding side effects.

"Each year, about 750,000 Americans undergo hip or knee replacement surgery and that number is growing rapidly. This is a major stride forward as we work toward better prevention of life-threatening blood clots in these patients," Raskob said.

He added that the development of new oral anticoagulant agents, like Apixaban, has raised hope of a standard of care for DVT prevention that is as effective as or more effective than current standard approaches as well as being equally safe and more convenient for patients.

Raskob also was a primary author in another study published in the same issue of The New England Journal of Medicine focusing on the treatment of patients with established deep vein thrombosis.

"Despite the best current prevention efforts, blood clots still occur. So, it is important to continue to work
'/>"/>

Contact: Diane Clay
diane-clay@ouhsc.edu
405-271-2323
University of Oklahoma
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. International consortium to examine the impact of medical devices on health and retirement
2. New international conference in bionic engineering
3. International clinical trial tests targeted drug for melanoma
4. Experts present new testing methods at international meeting in New Orleans, Nov. 14-18
5. Half of those travelling internationally not aware of potential health risks
6. From cholera to blindness, experts present cutting-edge research at international meeting
7. International summit held to stimulate collaborative clinical research on antiphospholipid syndrome
8. International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women
9. Boston, Oct. 21-24: Largest international pediatric oncology conference
10. International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health
11. International Robotic Urology Symposium+2011
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International research team reports major findings in prevention and treatment of blood clots
(Date:8/27/2015)... Mesa, AZ (PRWEB) , ... August 27, 2015 , ... ... out of more than 2,100 applicants worldwide, selected based on academic rigor, leadership and ... the attainment of a baccalaureate degree. , Sypher will receive a medallion and a ...
(Date:8/27/2015)... ... August 27, 2015 , ... According to an article ... Association have released new guidelines to educate doctors and patients on the best practices ... particular guidelines came in 2007, so the new version is taking into account nearly ...
(Date:8/27/2015)... ... August 27, 2015 , ... On May 30th, 2015, at the Adams County ... of the “Music With A Mission” benefit concert. For the past two years, “Music ... the underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized in part ...
(Date:8/27/2015)... ... 2015 , ... StayWell, a leading provider of patient education ... ready and available to all clients. All Krames Patient Education content has been ... targeted and return a more comprehensive data set of content than the ICD-9 ...
(Date:8/27/2015)... ... August 27, 2015 , ... Banc Intranets recently entered into ... will enable both Johnson City, Tenn.-based firms to work synergistically to promote similar products ... product that caters to organizations in the financial, commercial and services sectors. The software, ...
Breaking Medicine News(10 mins):Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:StayWell announces all health content is ICD-10 ready 2Health News:StayWell announces all health content is ICD-10 ready 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4
... international team of pathologists studied an initial 4,000 prostate cancer ... into the natural progression of the disease and how it ... British Journal of Cancer , could be used to develop ... of prostate cancer. Globally, prostate cancer is ...
... people worldwide, researchers say , WEDNESDAY, Sept. 23 (HealthDay ... only one injection produced promising results in animals, U.S. ... to undergo six shots over 28 days -- five ... rabies immunoglobulin. , The new replication-deficient rabies virus vaccine ...
... ... Training from American TeleCare, Inc. to Integrate Telehealth into the Education and Clinical Practice ... ... (ATI), Inc. announced that the Allied Health Department, University of Hawaii-Maui Community College (UH-Maui ...
... BERLIN, Sept. 23 Bayer HealthCare Pharmaceuticals ... today announced the full results from their first collaborative ... Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic ... advanced breast cancer. The data were presented at ...
... ... has been officially recognized by the City of Chicago. In honor of this day, The ... local celebrations. , ... (PRWEB) September 23, 2009 -- Christopher Reeve Day (9/25) has been officially recognized by the ...
... ... MD and Cell Biologist Jose Minguell, PhD,s adult stem cell human clinical ... Stem Cell Summit in Baltimore, MD. All of the trial patients ... diabetic patients reported pain from diabetic neuropathy has ceased. TCA Cellular ...
Cached Medicine News:Health News:Study reveals 2/3 of prostate cancer patients do not need treatment 2Health News:One Shot May Someday Replace Six for Rabies 2Health News:University of Hawaii-Maui Community College Selects American TeleCare for Allied Health Department's Nursing Telehealth Project 2Health News:University of Hawaii-Maui Community College Selects American TeleCare for Allied Health Department's Nursing Telehealth Project 3Health News:Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study 2Health News:Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study 3Health News:Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study 4Health News:Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study 5Health News:Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study 6Health News:First-Ever Christopher Reeve Day (9/25/09) to be Celebrated with Memorable Chicago Events 2Health News:Louisiana's TCA Cellular Therapy's Findings Reported at World Stem Cell Summit -- Patients' Legs Saved from Amputation Using Adult Stem Cells 2Health News:Louisiana's TCA Cellular Therapy's Findings Reported at World Stem Cell Summit -- Patients' Legs Saved from Amputation Using Adult Stem Cells 3
(Date:8/27/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 16, ... invited to listen to the live discussion via the ... at https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay ... the conclusion of the live event and accessible via ...
(Date:8/27/2015)... FREDERICK, Md. , Aug. 27, 2015  BioElectronics Corporation ... devices, announced today that three abstracts featuring the use ... presented at the 9 th Congress of the ... , 2-5 th September 2015. The Company will ... Dr Gianluca Bagnato , department clinical ...
(Date:8/27/2015)... August 27, 2015 The Elekta ... Boston on July 9th for ... effort to more fully exploit the potential of advances ... brain diseases. "As an established provider of ... to assume a leadership role - in collaboration with ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3
... Inc. (Nasdaq: BMRN ) announced today the appointment ... Board of Directors. "We are extremely pleased to ... Directors.  With experience, vision and proven strength in leadership and ... important role in the company," said Pierre Lapalme, Chairman of ...
... NEW YORK and ALLENDALE, N.J., Sept. 23 NeoStem, ... biopharmaceutical company with operations in the U.S. and China ... therapy company that serves the cell therapy industry from ... Jersey and California  today jointly announced the signing of ...
Cached Medicine Technology:BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 2BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 3NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement 2NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement 3NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement 4
... standard in corneal diagnostics. Precise Display ... membrane, stroma, Bowman's membrane and epithelial ... Broad Applications in Surgery and Pathology. ... evaluation, endothelial cell analysis, haze detection, ...
... the appearance of photo-aged skin, removes age ... telangiectasias, and broken capillaries. This innovative new ... treats pigmentary sun damage through a process ... IPL and the Nd:YAG Laser is optimized ...
... fun, affordable lenses available in a ... are available in prescription powers for ... in "Plano" for those who don't. ... Ultrasync technology. Incredibly comfortable, 10 fun, ...
Each jet black lens features a mesmerizing thin white line that spirals toward the center of the pupil....
Medicine Products: